Edition:
United States

Selecta Biosciences Inc (SELB.OQ)

SELB.OQ on NASDAQ Stock Exchange Global Market

8.50USD
16 Feb 2018
Change (% chg)

$-0.01 (-0.12%)
Prev Close
$8.51
Open
$8.47
Day's High
$8.72
Day's Low
$8.43
Volume
47,576
Avg. Vol
83,063
52-wk High
$24.00
52-wk Low
$8.00

Chart for

About

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The Company is engaged in the research and development of... (more)

Overall

Beta: --
Market Cap(Mil.): $189.86
Shares Outstanding(Mil.): 22.34
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Selecta Biosciences Says Expects To Report Initial Results For Phase 2 Clinical Trial Of SEL-212 In Chronic Severe Gout In April 2018

* SELECTA BIOSCIENCES SAYS EXPECTS TO REPORT INITIAL RESULTS FOR PHASE 2 CLINICAL TRIAL OF SEL-212 IN CHRONIC SEVERE GOUT IN APRIL 2018 - SEC FILING

Jan 08 2018

BRIEF-Selecta Biosciences Says CEO Werner Cautreels Plans Retirement at 2018 End

* SELECTA BIOSCIENCES ANNOUNCES CEO’S INTENT TO RETIRE AND TRANSITION PLAN

Jan 02 2018

BRIEF-Selecta Biosciences Announces FDA Acceptance Of Investigational New Drug Application For Lmb-100 And Svp-Rapamycin Combination Therapy

* SELECTA BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LMB-100 AND SVP-RAPAMYCIN COMBINATION THERAPY

Jan 02 2018

BRIEF-Selecta Biosciences announces Q3 loss per share $0.66

* Selecta Biosciences announces third quarter 2017 financial results and provides corporate update

Nov 07 2017

BRIEF-Selecta Biosciences names John Leaman chief financial officer

* Selecta Biosciences announces important additions to senior leadership team

Oct 26 2017

Deals of the day-Mergers and acquisitions

Aug 25 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Aug 25 2017

South Korea's CJ buys Brazil soy protein maker from Chile's Corpesca

SAO PAULO Brazilian soy protein maker Selecta said its owners had sold a 90 percent stake to South Korea's CJ CheilJedang Corp for 450 million reais ($143 million).

Aug 25 2017

South Korea's CJ buys Brazil soy protein maker from Chile's Corpesca

SAO PAULO, Aug 25 Brazilian soy protein maker Selecta said its owners had sold a 90 percent stake to South Korea's CJ CheilJedang Corp for 450 million reais ($143 million).

Aug 25 2017

EU clears Selecta's purchase of Dutch Pelican Rouge

BRUSSELS, Aug 25 EU antitrust regulators cleared Swiss vending services provider Selecta's proposed acquisition of Dutch peer Pelican Rouge, subject to the divestment of all Selecta's vending service activities in Finland.

Aug 25 2017

EU mergers and takeovers (Aug 24)

BRUSSELS, Aug 23 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Aug 24 2017

Competitors

Earnings vs. Estimates